Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Brodde

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 22, 2014
Cellular Stress Induced by Plasma-Derived Factor VIII ProductsMartin Brodde, Anja Müller, Beate Kehrel
Drug Delivery and Translational Research|March 23, 2022
A multistep in vitro hemocompatibility testing protocol recapitulating the foreign body reaction to nanocarriersValeria Perugini, Ruth Schmid, Ýrr Mørch, et al.
Platelets|November 1, 2006
Normal platelet reactivity in apolipoprotein E (apo E)-deficient mouseJerzy-Roch Nofer, Martin Brodde, Grazyna Herminghaus, et al.
International Journal of Biological Macromolecules|November 8, 2017
Oxidation of C-reactive protein by hypochlorous acid leads to the formation of potent platelet activatorMagdalena Boncler, Beate Kehrel, Rafał Szewczyk, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|May 6, 2020
Thrombogenicity of the p48 and anti-thrombogenic p48 hydrophilic polymer coating low-profile flow diverters in an in vitro human thrombin generation modelPervinder Bhogal, Tim Lenz-Habijan, Catrin Bannewitz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 4, 2013
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- miceFrancesco Potì, Fabio Gualtieri, Sandro Sacchi, et al.
Atherosclerosis|December 31, 2016
High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expressionRenata Feuerborn, Susen Becker, Francesco Potì, et al.
The Journal of Biological Chemistry|May 28, 2004
Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease)Jerzy-Roch Nofer, Grazyna Herminghaus, Martin Brodde, et al.
Circulation|January 24, 2007
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient miceJerzy-Roch Nofer, Martine Bot, Martin Brodde, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 22, 2014
Cellular Stress Induced by Plasma-Derived Factor VIII ProductsMartin Brodde, Anja Müller, Beate Kehrel
Drug Delivery and Translational Research|March 23, 2022
A multistep in vitro hemocompatibility testing protocol recapitulating the foreign body reaction to nanocarriersValeria Perugini, Ruth Schmid, Ýrr Mørch, et al.
Platelets|November 1, 2006
Normal platelet reactivity in apolipoprotein E (apo E)-deficient mouseJerzy-Roch Nofer, Martin Brodde, Grazyna Herminghaus, et al.
International Journal of Biological Macromolecules|November 8, 2017
Oxidation of C-reactive protein by hypochlorous acid leads to the formation of potent platelet activatorMagdalena Boncler, Beate Kehrel, Rafał Szewczyk, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|May 6, 2020
Thrombogenicity of the p48 and anti-thrombogenic p48 hydrophilic polymer coating low-profile flow diverters in an in vitro human thrombin generation modelPervinder Bhogal, Tim Lenz-Habijan, Catrin Bannewitz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 4, 2013
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- miceFrancesco Potì, Fabio Gualtieri, Sandro Sacchi, et al.
Atherosclerosis|December 31, 2016
High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expressionRenata Feuerborn, Susen Becker, Francesco Potì, et al.
The Journal of Biological Chemistry|May 28, 2004
Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease)Jerzy-Roch Nofer, Grazyna Herminghaus, Martin Brodde, et al.
Circulation|January 24, 2007
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient miceJerzy-Roch Nofer, Martine Bot, Martin Brodde, et al.
Pageof 1